The cell line is not validated yet.
CBCHi001-A-1
General#
Cell Line |
|
| hPSCreg Name | CBCHi001-A-1 |
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Last update | 1st April 2022 |
| User feedback | |
Provider |
|
| Generator | Beijing Chest Hospital (CBCH) |
External Databases |
|
| BioSamples | SAMEA13855333 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research: allowed
Clinical: not allowed
Commercial: not allowed
|
| Subclone of | |
Donor Information#
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
| BioSamples | SAMEA13855308 |
Ethics#
Also have a look at the ethics information for the parental line
CBCHi001-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation#
General |
|
|
The source cell information can be found in the parental cell line
CBCHi001-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions#
| Medium |
mTeSR™ Plus
|
Characterisation#
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
| SOX2 |
Yes |
|
||||
| SSEA-4 |
Yes |
|
Score:
| Marker | Present | Absent |
| mCpG | ||
| OCT4 |
Differentiation Potency
Genotyping#
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification#
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.